Powered by RND
PodcastsEducationHemeTalks: Conversations in Hematology Education
Listen to HemeTalks: Conversations in Hematology Education in the App
Listen to HemeTalks: Conversations in Hematology Education in the App
(524)(250,057)
Save favourites
Alarm
Sleep timer

HemeTalks: Conversations in Hematology Education

Podcast HemeTalks: Conversations in Hematology Education
American Society of Hematology
HemeTalks: Conversations in Hematology Education is the latest podcast channel by the American Society of Hematology (ASH)! Explore educational content crafted ...

Available Episodes

5 of 16
  • Advancing Sickle Cell Disease Care: A conversation between cellular therapy & BMT providers
    Are you a healthcare professional seeking clarity on the evolving treatments for sickle cell disease (SCD)? In this 20-minute episode, experts from cellular therapy and bone marrow transplantation (BMT) explore key updates in SCD care, including curative therapies, gene-editing innovations, and BMT approaches. They address practical challenges in integrating these treatments into practice and discuss strategies to improve access and outcomes. Tune in to discover how collaboration between cellular therapy and BMT providers is transforming care and paving the way for better patient experiences.  Learning Objectives Understand recent advancements in curative therapies, including gene editing and BMT, for sickle cell disease. Identify key challenges and barriers to integrating new treatments into clinical practice for SCD patients. Explore collaborative care strategies between cellular therapy and BMT providers to improve patient outcomes and access. 
    --------  
    20:42
  • Inside ASH 2024: Insights from the Education Program Co-Chairs
    Join us for an insightful podcast episode featuring the Co-Chairs of the upcoming 2024 ASH Annual Meeting, where we explore the planning process and strategic goals that shaped this year’s program. Discover how the Co-Chairs ensured the Education Program meets the diverse needs of the hematology community, and the unique challenges faced during the planning and how they were overcome. Gain exclusive insights into what makes this event the premier gathering for professionals in the field. Whether attending in person or virtually, find out how you can maximize your experience and apply the latest advancements to your practice or research.Learning Objectives:Understand the Planning Process: Learn about the strategic goals, collaborative efforts, and decision-making that guided the design of the Education Program for the 66th ASH Annual Meeting, ensuring it addresses the diverse needs of the hematology community.Overcome Planning Challenges: Learn about the specific challenges encountered during the planning of this year’s program and how they were effectively managed to deliver a meaningful experience for attendees.Impact on Practice and Research: Understand how this year’s program is designed to impact attendees' practices and research, fostering advancements in the field of hematology.
    --------  
    16:06
  • Blood Transfusion Safety: TRALI vs TACO
    Join us as we explore blood transfusion safety, focusing specifically on Transfusion-Related Acute Lung Injury (TRALI) and Transfusion-Associated Circulatory Overload (TACO). Tailored for general hematologists with a foundational understanding of transfusion medicine, this session delves into the pathophysiology, clinical presentation, diagnostic criteria, and management strategies for TRALI and TACO. Through advanced discussions, participants will deepen their knowledge of these complications, enabling them to recognize, diagnose, and manage TRALI and TACO effectively in clinical practice.Learning Objectives:Gain a thorough understanding of the pathophysiology and clinical presentation of TRALI and TACO.Familiarize with the diagnostic criteria and differential diagnosis of TRALI and TACO.Develop effective management strategies for TRALI and TACO to ensure transfusion safety and enhance patient outcomes.
    --------  
    20:03
  • Advancing Sickle Cell Disease Care: Navigating Gene Therapy
    Are you a hematologist or a generalist provider seeking clarity on how to best counsel patients with sickle cell disease (SCD) who are interested in gene therapy? Join us for a podcast session focused on important patient considerations for gene therapy, tailored for SCD providers and clinicians. This session aims to provide practical insights to facilitate clear communication between providers, patients with SCD, and their families about treatment options.Learning ObjectivesUnderstand the Basics of Gene Therapy Treatments & SCD: By the end of the podcast, listeners will be able to identify some basic tenants of transformative treatments for sickle cell disease (SCD), focusing on how gene therapy treatments compare to other disease modifying treatments.Counseling Patients and Families: Listeners will be given suggestions on what key information to provide to patients and families that are interested in gene therapies, especially considering the build-up to gene therapy and also potential long-term effects.Enhance Communication Skills: This episode will suggest effective communication strategies to provide patients with both perspective and empathy while discussing gene therapy and other treatment options.
    --------  
    17:11
  • Updates in Thalassemia: New Challenges and Novel Treatment Approaches
    Speakers: Alexis Thompson, MD, and Sujit Sheth, MDDescription:For general hematologists with a foundational understanding of thalassemia, this episode discusses the changing demographics due to immigration and refugee resettlement. It covers the diagnosis process from newborn screening to older individuals, emphasizing genetic testing due to numerous mutations and varied phenotypes. The importance of correctly diagnosing older individuals previously misdiagnosed with iron deficiency refractory to treatment is highlighted. The episode also addresses regular transfusions, iron chelation, and monitoring for complications, along with advances in blood supply safety, reduced alloimmunization risks through extended typing, and MRI monitoring. Finally, novel agents in practice and development, including luspatercept, PK activators, and gene therapy, will be explored. Learning Objectives:Understand the changing landscape of thalassemia in the US. Revisit the state-of-the-art diagnostic and treatment approaches. Learn about novel therapeutics in the thalassemia field
    --------  
    20:19

More Education podcasts

About HemeTalks: Conversations in Hematology Education

HemeTalks: Conversations in Hematology Education is the latest podcast channel by the American Society of Hematology (ASH)! Explore educational content crafted by subject-matter experts from ASH, tailored to fulfill your professional education requirements. Whether you are a clinician or researcher, HemeTalks provides innovative education designed for every career stage and subspecialty.
Podcast website

Listen to HemeTalks: Conversations in Hematology Education, Good Life Project and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features

HemeTalks: Conversations in Hematology Education: Podcasts in Family

Social
v7.1.1 | © 2007-2024 radio.de GmbH
Generated: 12/26/2024 - 11:45:34 AM